The editors in chief are Andrel V. Gudkov who resides in Roswell Park Cancer Institute and Mikhail Blagosklonny. The journal is preoccupied and indexed in index PubMed and PubMed central, science citation index expanded which is also known as SciSearch, Biological Abstracts, Embase, BIOSIS Previews, Scopus, Journal Citation Report/Science Edition, Directory of open Access Journal and OAlster.

With time, the journal has diversed into new therapeutic agents, the impact of management programs and protocols on patient perspectives such as satisfaction, quality of life and adherence.

The journal goes through the evidence behind new and existing therapies in terms of improving outcomes and aims to define their usage in terms of uptake and acceptance by the health care professionals and more primarily the patient.

Research Gate has it that the impact factor of the journal oncotarget is considerably high. Listed below is the impact factor of the journal throughout the years.

Journal Impact

2016 Available in summer 2017

2015 5.00

2014 6.35

2013 6.62

2012 6.73

2011 4.78

In a study recently published by Oncotarget, researchers have found that the chemical found in e-cigarette vapor are just as damaging as tobacco smoke. This is the first ever scientific study that addresses the harmful effects of e-cigarette’s on oral health and its daunting effects on cellular and molecular level.

They also discovered that the flavouring chemical plays a vital role in damaging cells in the mouth. Such damage can lead to various health problems including tooth loss, mouth cancer and different gum diseases.

E-cigarettes are battery-operated devices that contain a battery, heating device and a cartridge that holds the chemical liquid. The heating device vaporizes the liquid and the vapor is inhaled by the user. While e-cigarette liquid solution does not contain tobacco which is the harmful component in conventional cigarettes, they do contain nicotine and other various chemicals and flavouring agents.